This on-demand presentation explores how top-down mass spectrometry (MS/MS) provides direct and quantitative assessments of highly modified CRISPR guide RNAs (gRNAs), ensuring their accuracy and safety for therapeutic applications.
Discover:
This presentation is for you if:
Don't miss this opportunity to learn how top-down MS/MS can revolutionize your CRISPR research and development.
By the end of this presentation, you will have:
Luis A. Macias, Ph.D., Mass Spectrometry Scientist, Verve Therapeutics, Houston, TX, USA
Luis joined Verve in 2022 as a mass spectrometry scientist focusing on support and development of gRNA characterization methods. Prior to joining Verve, Luis was a graduate student in the Brodbelt lab at the University of Texas, where he developed mass spectrometry-based methods to examine structural features of proteins and lipids.
For Research Use Only. Not for use in clinical diagnostic procedures.